Finally, metformin was found to inhibit mTORC1 and activate HLH-30, the TFEB homolog in C. elegans [45], raising the possibility that activation of TFEB may be a shared property of chemically diverse agents that have already been nominated for HDT of TB. Here, TFEB is linked to tuberculosis.